基本信息
views: 50
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
研究方向为脑卒中、老年痴呆和胶质瘤等重大神经系统疾病的脑损伤机制与药物研发。研究近年集中于糖代谢关键酶对脑组织的损伤作用,发现新的脑卒中药物靶点己糖激酶2(HK2),并展开HK2促进炎症、外泌体生成等脑损伤机制探索;承担1.1类急性缺血性脑卒中新药YC-6(已进入II期临床试验)的临床前药效学与神经保护机制的研究,主持实施了YC-6及其同系物预防急性高原性脑损伤等其他适应症应用的研究;作为十一五重大新药创制负责人,主持了抗脑缺血基因工程直接溶栓药物研发。此外,还参与恶性实体瘤的诱导分化治疗研究,发现生物毒素、小分子及其组合物诱导胶质瘤细胞分化的作用,并展开恶性胶质瘤诱导分化治疗及其分子机制研究。
Research Interests
Papers共 110 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yuwei Zhou, Chen Chen,Yupin Chen, Yuxuan Ding,Shenglong Li,JiaXin Wu, ShiRan Hong,BingZheng Lu, Huafeng Liang,Ying Liu,Ying Ouyang,Wei Yin,
INTERNATIONAL IMMUNOPHARMACOLOGY (2024)
YuWei Zhou,Chen Chen,YuPin Chen, YuXuan Ding,ShengLong Li,JiaXin Wu, ShiRan Hong,BingZheng Lu, HuaFeng Liang,Ying Liu,Ying Ouyang,Wei Yin,
International immunopharmacology (2024): 111486-111486
Xincheng Liu,Cui Guo,Tiandong Leng, Zhen Fan,Jialuo Mai,Jiehong Chen,Jinhai Xu, Qianyi Li,Bin Jiang,Ke Sai,Wenzhuo Yang,Jiayu Gu,
Ke Zhong,Kejia Liu, Yu Song,Sitai Chen,Xia Hu,Ruiqi Xue,Xueying Ma, Shaojian Li,Jingwen Yang,Zhenhong Deng,Xiaoqiu Zhu, Mingjun Yuan,
Molecular Neurobiologypp.1-16, (2023)
AGING CELLno. 10 (2023)
Cited0Views0Bibtex
0
0
Chen Chen,YuWei Zhou,XinPeng Ning,ShengLong Li,DongDong Xue,CaiLv Wei,Zhu Zhu,LongXiang Sheng,BingZheng Lu,Yuan Li,XiaoYuan Ye, YunZhao Fu,
DongDong Xue,CaiLv Wei,YueHan Zhou, Kai Wang,YuWei Zhou, Chen Chen,Yuan Li,LongXiang Sheng,BingZheng Lu,Zhu Zhu, Wei Cai,XinPeng Ning,
Zhijie Chen,Yingqian Zhong,Jiehong Chen,Shuxin Sun, Wenfeng Liu, Yu Han,Xincheng Liu,Cui Guo,Depei Li,Wanming Hu, Peiyu Zhang,Zhuopeng Chen,
Cell Death & Diseaseno. 5 (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn